Skip to main content

Namma Lawyers: How Bangalore Has Grown Into a Thriving Legal Hub

by Nimitt Dixit |

 

Bengaluru's explosive tech scene, startup ecosystem, and craft beer culture have spawned a new breed of specialised lawyers, transforming the once-sleepy city into one of India's most dynamic legal markets. This burgeoning legal landscape is attracting both homegrown and national law firms to establish and rapidly expand their presence in…

FORUM: Collective Advantage

by Nimitt Dixit |

Collaboration is the most powerful driver of client institutionalisation. According to Thomson Reuters’ research, clients who identify collaborative teams within an outside law firm spend an average of 56 percent of their budget at that firm — more than twice the average share of spend received by the firms that clients use the most.

EXPLAINER: Unpacking the GIFT City Remittance Regime

by Nimitt Dixit |

The Reserve Bank of India has recently expanded the scope of remittances to International Financial Services Centres (IFSCs), permitting Indian residents to open foreign currency accounts in the country’s first IFSC, Gujarat International Finance Tec-City, also known as GIFT City.

Q&A: Beyond the Boundary: How Law Is Influencing Sports Governance

by Nimitt Dixit |

Nandan Kamath is a sports lawyer and the founder of LawNK, a law firm based in Bengaluru specialising in sports, technology, and media law, representing a diverse clientele that includes national and international sports federations, leagues, teams, sponsors, and athletes.

IN-HOUSE INSIGHT: How General Counsel Can Set the Gold Standard

by Isha Rathnam |

Over my close to 20 years in the legal profession, I have heard and read many preconceived notions about in-house versus law firm experience.

INFRASTRUCTURE: Building Growth

by Nimitt Dixit |

India’s economic growth is intrinsically linked to its infrastructure development, and the government is doing everything possible and more to attract private investment. However, concerns about a weaker NDA alliance, high counterparty risk, and a slow court system remain high on investors’ minds.

EXPLAINER: Does Covishield’s alleged health concerns expose it to legal liability?

by Nimitt Dixit |

COVID-19 vaccine-maker AstraZeneca was in the spotlight in May following the company’s admission in a UK court proceeding of the possibility of a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS) associated with its vaccines. More than 50 individuals have alleged the vaccine resulted in death and serious injuries from TTS.